Expertise in
8
conditions

Peter A. Ringleb

Heidelberg, BW, DE 
Expertise in
8
conditions
Heidelberg, BW, DE 

Overview

Peter Ringleb practices practicing medicine in Heidelberg, Germany.

Mr. Ringleb is highly rated in 8 conditions, according to our data. His clinical expertise encompasses Stroke, Carotid Artery Disease, Transient Ischemic Attack (TIA), Thrombectomy, and Stent Placement.

He is actively involved in clinical research, co-authoring 319 peer reviewed articles and participating in 3 clinical trials.

Gender

Male

Locations

Heidelberg, BW, Germany
Other Locations
Ludwigshafen Am Rhein, RP, Germany
Salem, BW, Germany
Charité Universitätsmedizin Berlin And Neurologie Der Rehaklinik Medical Park Humboldtmühle, Campus Lübeck, Luebeck, SH, Germany
Munich, BY, Germany
Mannheim, BW, Germany

Clinical Research

Clinical research consists of overseeing clinical studies of patients undergoing new treatments and therapies, and publishing articles in peer reviewed medical journals. Experts who actively participate in clinical research are generally at the forefront of the fields and aware of the most up-to-date advances in treatments for their patients.

3 Clinical Trials

PRediction of Acute Coronary Syndrome in Acute Ischemic StrokE
PRediction of Acute Coronary Syndrome in Acute Ischemic StrokE
Enrollment Status: Completed
Publish Date: March 26, 2025
Intervention Type: Diagnostic test
PREvention of STroke in Intracerebral haemorrhaGE Survivors With Atrial Fibrillation (PRESTIGE-AF)
PREvention of STroke in Intracerebral haemorrhaGE Survivors With Atrial Fibrillation (PRESTIGE-AF)
Enrollment Status: Completed
Publish Date: January 13, 2025
Intervention Type: Drug
Study Drugs: Apixaban, Dabigatran, Edoxaban, Rivaroxaban
Study Phase: Phase 3
Platelet-Oriented Inhibition in New TIA and Minor Ischemic Stroke (POINT) Trial
Platelet-Oriented Inhibition in New TIA and Minor Ischemic Stroke (POINT) Trial
Enrollment Status: Terminated
Publish Date: December 04, 2018
Intervention Type: Drug
Study Phase: Phase 3
View 2 Less Clinical Trials

317 Total Publications

Role of Perfusion Parameters on Outcomes and Safety of Endovascular Therapy in Posterior Cerebral Artery Stroke.
Role of Perfusion Parameters on Outcomes and Safety of Endovascular Therapy in Posterior Cerebral Artery Stroke.
Journal: Stroke
Published: July 09, 2026

Frequently Asked Questions about Peter A. Ringleb

Is Peter A. Ringleb a top-rated expert for Stroke?

MediFind is an objective health platform that identifies experts based on real-world data. Peter A. Ringleb is classified as an Elite expert for Stroke, meaning they are among the top experts in the country for this condition. This ranking is based on their volume of patients, published research, and peer connections.

Does Peter A. Ringleb participate in research or clinical trials?

Yes. Peter A. Ringleb has published 317 articles and abstracts on conditions like Stroke. You can view a list of Peter A. Ringleb's latest peer-reviewed publications and clinical trial participation on their profile to see if they are active in new treatments.

Areas of Expertise

MediFind evaluates expertise by pulling from factors such as number of articles a doctor has published in medical journals, participation in clinical trials, speaking at industry conferences, prescribing and referral patterns, and strength of connections with other experts in their field.

Learn more about MediFind’s expert tiers

Find Mr. Ringleb's expertise for a condition
ConditionClose
View All 19 Experienced Conditions
Want to save this expert for later?
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
 
 
 
 
Learn about our expert tiers
Learn More
Are you the provider on this profile?
Claim Profile